Top 10 Gene Therapy Stocks to Buy According to Hedge Funds
On February 23, Lauren Goodwin, New York Life Investments, appeared on CNBC’s ‘Closing Bell’ to talk about the state of equity markets and tariff uncertainties.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AQR Capital Management Cliff Asness | 6,686,916 | $395,196,725 | +13% | 0.21% |
| 2. | Viking Global Andreas Halvorsen | 6,036,936 | $358,775,106 | -28% | 0.95% |
| 3. | Millennium Management Israel Englander | 3,037,616 | $180,525,519 | +16% | 0.08% |
| 4. | Vestal Point Capital Ryan Wilder | 3,000,000 | $178,290,000 | +262% | 6.06% |
| 5. | Deep Track Capital David Kroin | 2,300,000 | $136,689,000 | +9154% | 2.44% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $86.75 | 3,625 | $314,468.75 | 10,905 | 2022-10-31 | Filing | |
| $78.84 | 900 | $70,955.37 | 30,740 | 2020-08-31 | Filing | |
| $78.22 | 11,900 | $930,759.69 | 29,840 | 2020-08-31 | Filing | |
| $21.76 | 161 | $3,503.36 | 100,574 | 2012-10-31 | Filing | |
| $21.76 | 548 | $11,924.48 | 15,294 | 2012-10-31 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $60.38 | 6,326 | $381,937.31 | 37,578 | 2026-02-26 | Filing | |
| $61.36 | 26,061 | $1,599,102.96 | 72,453 | 2026-02-26 | Filing | |
| $59.31 | 1,786 | $105,927.66 | 14,173 | 2025-05-20 | Filing | |
| $64.92 | 273 | $17,723.16 | 32,700 | 2025-05-02 | Filing | |
| $71.52 | 1,295 | $92,618.40 | 16,955 | 2025-03-19 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,135,108 | $1,137,199,439 | 0.02% | |
| 2. | 18,127,847 | $1,077,337,946 | 0.02% | |
| 3. | 14,572,384 | $866,036,781 | 0.47% | |
| 4. | 14,549,314 | $864,665,732 | 0.65% | |
| 5. | 7,531,080 | $447,572,084 | 0.05% |